: Thursday, August 13, 2020
Korea‘s Bio Industry
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Hospitals resort to robots amid Covid-19 pandemic
While healthcare workers...
[Photo News] Trainee doctors hit streets against increasing physicians
Members of the Korean In...
[Interview with global pharma] 'Roche Korea's endeavors to build agile corporate culture'
[Analysis] Revocation of Medytox license tolls death knell for once-promising biotech firm
[ASCO 2020 ⑥] Alteogen confirms safety, efficacy of HER2 breast cancer therapy
[ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform
[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe
[ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety
Genexine said that the c...
[ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody
GC has come up with opti...
[ASCO 2020 ①] Samsung Bioepis’ anticancer biosimilar shows equal quality to original drug
[Up-and-coming medical startups of 2020] CES 2020 award-winning startup Exosystems unveils ‘exoRehab’
[Up-and-coming medical startups of 2020] SMD Solution provide full dental care for everyone
Adolescent Protection Policy
E-mail address privacy
The Korean Doctors’ Weekly Co., Ltd.
76-1, Dongmak-ro, Mapo-gu, Seoul, Korea
Email : email@example.com
Title : Korea Biomedical Review
Online newspaper registration number : Seoul 아 04285
Date of registration : December 19, 2016
Publishing date : February 22, 2017
Publisher-Editor : Yang Kyung-cheol
Chief Executive Officer : Yang Kyung-cheol
Executive Editor : Choi Sung-jin
pyright © 2020 KBR. All rights reserved.
Back to Top